Jéssika Martins Siqueira

Hemoglobin levels play an important role in oxygen delivery to skeletal muscle, and reduced levels may impair muscle function and contribute to sarcopenia, particularly in patients with cancer. The aim of the present study was to evaluate the influence of hemoglobin levels on muscle mass and function in patients with digestive tract cancer. Methods: Patients of both sexes aged up to seventy years with cancers of the digestive system undergoing surgical and clinical treatment at an oncology referral center were included. Hemoglobin levels were assessed using a blood count, and the risk of sarcopenia was estimated using the Mini Sarcopenia Risk Assessment (MSRA). A total of 82 patients were evaluated, with a mean age of 55.4 years. Colon cancer was the most prevalent (41.6%), followed by rectal (18.3%) and stomach (14.6%) cancers. The risk of sarcopenia was estimated at 85.4%, and the prevalence of low hemoglobin levels was 71.9%; 35.4% of patients presented moderate hemoglobin depletion. Hemoglobin levels showed a moderate correlation with gait speed and a slight correlation with calf circumference, handgrip strength, and MSRA score. In conclusion, the risk of sarcopenia and low hemoglobin levels are present in patients with digestive tract cancer. Additionally, hemoglobin levels positively correlate with indicators of muscle function and the risk of sarcopenia.

Juçara is an important element for biodiversity in the Atlantic Forest, not only providing a rich source of nutritional and bioactive compounds, but also holding promising potential for sustainability. However, despite its virtues, there remains a dearth of studies fully exploring its potential. In our pioneering study, conducted using a panel of eight trained specialists, we delved into a sensory analysis of dehydrated juçara pulp, employing both descriptive analysis and the temporal dominance of sensations (TDS) technique. The findings revealed striking differences between juçara and açaí, not only in terms of flavor and aroma, but also in their potential to drive more mindful eating habits. By promoting the consumption of juçara, we are supporting the sustainability of the Atlantic Forest, where it is cultivated in an environmentally responsible manner. Thus, we are contributing to the preservation of this unique ecosystem and the well-being of local communities.

Background and aims: Juçara is a fruit of ecological and nutritional importance. Its fruits represent an option for the sustainable use of the plant due to its vulnerability to extinction. Thus, the aim of this review was to analyze clinical and experimental studies and highlight the literature gaps regarding the effects of supplementation with Juçara on health. Methods: For this scoping review, we consulted the Medline (PubMed), Science Direct, and Scopus databases in March, April, and May 2022. Experimental studies and clinical trials published in the last ten years (2012–2022) were analyzed. Data were synthesized and reported. Results: A total of 27 studies were included, 18 of which were experimental studies. Of these, 33% evaluated inflammatory markers associated with fat accumulation. Most of these studies (83%) used pulp in lyophilized form, and the others (17%) involved juçara extract mixed in water. In addition, 78% of the studies showed positive results with respect to the lipid profile, reduction of oncological lesions, inflammation, microbiota modulation, and improvement in obesity and glycemia-related metabolic complications. Nine clinical trials with results similar to those of experimental trials were found. The majority (56%) were chronic (four to six weeks into the intervention), and 44% were acute. Three offered juçara supplementation in the form of juice, four used freeze-dried pulp, two used fresh pulp, and one used a 9% dilution. The dose was fixed at 5 g, but the dilution ranged from 200 to 450 mL. These trials assessed mainly healthy, physically active, and obese individual adults (19–56 years old), and cardioprotective and anti-inflammatory effects, as well as improvement in the lipid profile and prebiotic potential, were observed. Conclusion: Juçara supplementation showed promising results with respect to its effect on health. However, further studies are needed to clarify these possible effects on health and their mechanisms of action.

An excess of body fat is one of the biggest public health concerns in the world, due to its relationship with the emergence of other health problems. Evidence suggests that supplementation with long-chain polyunsaturated fatty acids (omega-3) promotes increased lipolysis and the reduction of body mass. Likewise, this clinical trial aimed to evaluate the effects of supplementation with krill oil on waist circumference and sagittal abdominal diameter in overweight women. This pilot, balanced, double-blind, and placebo-controlled study was carried out with 26 women between 20 and 59 years old, with a body mass index >25 kg/m². The participants were divided into the control (CG) (n = 15, 3 g/daily of mineral oil) and krill oil (GK) (n = 16, 3 g/daily of krill oil) groups, and received the supplementation for eight weeks. Food intake variables were obtained using a 24 h food recall. Anthropometric measurements (body mass, body mass index, waist circumference, and sagittal abdominal diameter) and handgrip strength were obtained. After the intervention, no changes were found for the anthropometric and handgrip strength variables (p > 0.05). Regarding food intake, differences were found for carbohydrate (p = 0.040) and polyunsaturated (p = 0.006) fatty acids, with a reduction in the control group and an increase in krill oil. In conclusion, supplementation with krill oil did not reduce the waist circumference and sagittal abdominal diameter. Therefore, more long-term studies with a larger sample size are necessary to evaluate the possible benefits of krill oil supplementation in overweight women.